Showing results (911-920 of 929) with videos related to
Sort By:
Pageof 93
Journal of Psychiatric Research|March 15, 2022
Neural substrates of emotional conflict with anxiety in major depressive disorder: Findings from the Establishing Moderators and biosignatures of Antidepressant Response in Clinical Care (EMBARC) randomized controlled trialJoseph M Trombello, Crystal M Cooper, Cherise Chin Fatt, et al.Journal of Affective Disorders|March 18, 2026
Heated yoga thaws depression: A dose-response analysis from a randomized controlled trialDaniel I Copeland, Naoise Mac Giollabhui, Simmie Foster, et al.Journal of Psychiatric Research|April 4, 2016
Establishing moderators and biosignatures of antidepressant response in clinical care (EMBARC): Rationale and designMadhukar H Trivedi, Patrick J McGrath, Maurizio Fava, et al.Behavioral Sciences (Basel, Switzerland)|August 25, 2023
Reward Behavior Disengagement, a Neuroeconomic Model-Based Objective Measure of Reward Pathology in Depression: Findings from the EMBARC TrialMichael A Giles, Crystal M Cooper, Manish K Jha, et al.Controlled Clinical Trials|April 6, 2004
Sequenced treatment alternatives to relieve depression (STAR*D): rationale and designA John Rush, Maurizio Fava, Stephen R Wisniewski, et al.International Clinical Psychopharmacology|January 17, 2026
Patient treatment preference as a predictor of clinical outcomes in subjects with treatment-resistant depression: a comparative effectiveness research trial for antidepressant incomplete and nonresponders with treatment-resistant depression (ASCERTAIN-TRD)Stefania Chaikali, Clotilde Guidetti, Madhukar H Trivedi, et al.Molecular Psychiatry|March 7, 2024
Comparative effectiveness research trial for antidepressant incomplete and non-responders with treatment resistant depression (ASCERTAIN-TRD) a randomized clinical trialGeorge I Papakostas, Madhukar H Trivedi, Richard C Shelton, et al.International Clinical Psychopharmacology|May 13, 2026
Association between anxious depression and clinical outcomes in subjects with treatment-resistant depression: a comparative effectiveness research trial for antidepressant incomplete and non-responders with treatment-resistant depression (ASCERTAIN-TRD)Stefania Chaikali, Clotilde Guidetti, Silvia Ioannou, et al.Journal of Affective Disorders|July 9, 2025
Effect of augmentation with aripiprazole or augmentation with repetitive transcranial magnetic stimulation versus switching to the antidepressant venlafaxine extended release/duloxetine on cognition: A comparative effectiveness research trial for antidepressant incomplete and non-responders with treatment-resistant depression (ASCERTAIN-TRD)Clotilde Guidetti, Stefania Chaikali, Madhukar H Trivedi, et al.The Journal of Clinical Psychiatry|October 26, 2023
A Randomized Controlled Trial of Community-Delivered Heated Hatha Yoga for Moderate-to-Severe DepressionMaren B Nyer, Lindsey B Hopkins, Megha Nagaswami, et al.Pageof 93